No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs548352554 |
chr6:131422008-131422009 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs549613246 |
chr6:131422082-131422083 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs200213504 |
chr6:131422101-131422102 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs150802947 |
chr6:131422110-131422111 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs373877292 |
chr6:131422117-131422118 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs1555611 |
chr6:131422119-131422120 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs1555610 |
chr6:131422121-131422122 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs10529890 |
chr6:131422127-131422128 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs62422411 |
chr6:131422129-131422130 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs201911121 |
chr6:131422131-131422132 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs184617175 |
chr6:131422164-131422165 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs528714950 |
chr6:131422172-131422173 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs139572718 |
chr6:131422206-131422207 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs538540675 |
chr6:131422250-131422251 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs12665208 |
chr6:131422253-131422254 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs539337112 |
chr6:131422257-131422258 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs571650488 |
chr6:131422298-131422299 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs188332489 |
chr6:131422299-131422300 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs76509167 |
chr6:131422301-131422302 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs536245264 |
chr6:131422306-131422307 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs554672730 |
chr6:131422334-131422335 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs573273125 |
chr6:131422339-131422340 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs112790508 |
chr6:131422405-131422406 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs6915839 |
chr6:131422545-131422546 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
25 |
rs6915845 |
chr6:131422563-131422564 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs563153536 |
chr6:131422652-131422653 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs180804874 |
chr6:131422666-131422667 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs150658647 |
chr6:131422718-131422719 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs529760459 |
chr6:131422736-131422737 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs185789144 |
chr6:131422737-131422738 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs560022717 |
chr6:131422757-131422758 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs191432575 |
chr6:131422765-131422766 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs181154613 |
chr6:131422775-131422776 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs571811602 |
chr6:131422782-131422783 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs13218427 |
chr6:131422784-131422785 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs550912406 |
chr6:131422790-131422791 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs569187620 |
chr6:131422838-131422839 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs536283076 |
chr6:131422840-131422841 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs149833206 |
chr6:131422872-131422873 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs566726366 |
chr6:131422876-131422877 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs534304107 |
chr6:131422933-131422934 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs558741637 |
chr6:131422938-131422939 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs577008291 |
chr6:131422964-131422965 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs55996418 |
chr6:131422970-131422971 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
45 |
rs556524418 |
chr6:131422975-131422976 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs539318274 |
chr6:131423024-131423025 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs59327805 |
chr6:131423026-131423027 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs368099752 |
chr6:131423028-131423029 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs368634990 |
chr6:131423033-131423034 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs117751557 |
chr6:131423049-131423050 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|